Kenvue stock rebounds: Tylenol maker rises 6% after Donald Trump’s autism claims; analysts see limited legal impact
Shares of Tylenol maker Kenvue rebounded sharply on Tuesday, recovering from a steep fall triggered by President Donald Trump’s unfounded remarks linking the drug to autism.At the opening bell, Kenvue shares climbed more than 6 per cent, a day after plunging 7.5 per cent, AP reported. Trump had repeatedly instructed pregnant women to avoid Tylenol…